TamVH, SchillingAN, VoG. Pharmacodynamics of polymyxin B against Pseudomonas aeruginosa. Antimicrob Agents Chemother2005; 49: 3624–30. DOI 10.1128/AAC.49.9.3624-3630.2005
2.
PastewskiAA, CarusoP, ParrisAR. Parenteral polymyxin B use in patients with multidrug-resistant gram-negative bacteremia and urinary tract infections: a retrospective case series. Ann Pharmacother2008; 42: 1177–87. DOI 10.1345/aph.1K346
3.
D'AgataEM. Rapidly rising prevalence of nosocomial multidrug-resistant gram-negative bacilli: a nine year surveillance study. Infect Control Hosp Epidemiol2004; 25:842–6. DOI 10.1086/502306
4.
KellumJA, BellomoR, RoncoC. Definition and classification of acute kidney injury. Nephron Clin Pract2008; 109: c182–7. DOI 10.1159/000142926
5.
NguyenM, EschenauerGA, BryanM. Carbapenem-resistant Klebsiella pneumoniae bacteremia: factors correlated with clinical and microbiological outcomes. Diagn Microbiol Infect Dis2010; 67:180–4. DOI10.1016/j.diagmicrobio.2010.02.001
